These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. SIV vaccines: current status. The role of the SIV-macaque model in AIDS research. Gardner M Vaccine; 1991 Nov; 9(11):787-91. PubMed ID: 1759500 [TBL] [Abstract][Full Text] [Related]
30. Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates. Le Grand R; Dereuddre-Bosquet N; Dispinseri S; Gosse L; Desjardins D; Shen X; Tolazzi M; Ochsenbauer C; Saidi H; Tomaras G; Prague M; Barnett SW; Thiebaut R; Cope A; Scarlatti G; Shattock RJ J Virol; 2016 Jun; 90(11):5315-5328. PubMed ID: 27009957 [TBL] [Abstract][Full Text] [Related]
31. SIV and FIV vaccine studies at UC Davis: 1991 update. Gardner M; Yamamoto J; Marthas M; Miller C; Jennings M; Rosenthal A; Luciw P; Planelles V; Yilma T; Giavedoni L AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1495-8. PubMed ID: 1334682 [No Abstract] [Full Text] [Related]
32. Summary of the SIV Working Group. Schultz AM AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1439-40. PubMed ID: 1466977 [No Abstract] [Full Text] [Related]
33. Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. Cranage MP; Polyanskaya N; McBride B; Cook N; Ashworth LA; Dennis M; Baskerville A; Greenaway PJ; Corcoran T; Kitchin P AIDS Res Hum Retroviruses; 1993 Jan; 9(1):13-22. PubMed ID: 8427714 [TBL] [Abstract][Full Text] [Related]
34. 25 years of HIV research! ... and what about a vaccine? Appay V Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891 [TBL] [Abstract][Full Text] [Related]
35. Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge. Takahara Y; Matsuoka S; Kuwano T; Tsukamoto T; Yamamoto H; Ishii H; Nakasone T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T Biochem Biophys Res Commun; 2011 May; 408(4):615-9. PubMed ID: 21531211 [TBL] [Abstract][Full Text] [Related]
36. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques. Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675 [TBL] [Abstract][Full Text] [Related]
37. DNA vaccination for HIV-1 and SIV. Barouch DH; Letvin NL Intervirology; 2000; 43(4-6):282-7. PubMed ID: 11251383 [TBL] [Abstract][Full Text] [Related]
38. Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine. Hirsch VM; Goldstein S; Hynes NA; Elkins WR; London WT; Zack PM; Montefiori D; Johnson PR J Infect Dis; 1994 Jul; 170(1):51-9. PubMed ID: 8014520 [TBL] [Abstract][Full Text] [Related]
39. AIDS vaccines show promise in primates. Clin Infect Dis; 2001 Oct; 33(7):i-ii. PubMed ID: 11592258 [No Abstract] [Full Text] [Related]
40. Cytotoxic T lymphocytes in AIDS pathogenesis: lessons to be learned from the macaque model of simian immunodeficiency virus infection. Geretti AM; Hulskotte E; Osterhaus AD J Gen Virol; 1998 Mar; 79 ( Pt 3)():415-21. PubMed ID: 9519818 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]